A Twin Cities company said it could offer protection from drug-resistant staph infections Tuesday.

The product claims to kill germs on contact and the treatments are gaining national attention.

The company called JYMRSA sells itself as the next generation of infectious disease control and prevention.

"We are able to kill, not encapsulate, but kill the bacteria that causes MRSA, VRA, and many other bacteria, that are extremely dangerous to people," said JYMRSA representative Joe Leintz.

The Federal government first developed decontaminating foam to combat things like anthrax and biological warfare. JYMRSA said it adapted the agent for commercial use.

"Most of the ingredients in our product are found in your medicine cabinet right now, just no one has ever taken those ingredients and combined them and blended them in this way," said JYMRSA Dr. Todd Leonard.

The company said it tests prove the fog kills MRSA and E.coli. It hopes to save lives by targeting places like hospitals, day care centers and locker rooms.

Professor of microbiology, Patrick Schlievert, said he’d have to test the product to fully understand its effectiveness. Although he admits cleaning doesn’t hurt, Schlievert said person-to-person contact is the bigger threat.

"What really has to be done, is good hygiene; washing your hands, do the kinds of things hospitals have in place," said Schlievert.

Fogging a room can take a few minutes and everything it touches is safe a short time later. The cost to treat the average locker room is $1,500. To treat an entire hospital for a year would cost $350,000.

JYMRSA said it is a small price to pay to protect people from so-called ‘superbugs.’ The company said it would meet with the Mayo Clinic Wednesday to discuss potential uses for the fog there.

JYMRSA said the product has already been used in local schools and may be marketed to homeowners with mold problems.